Digital Therapeutic Cybersecurity: Know Your Data Flow
A robust digital therapeutics cybersecurity system is integral to protecting users’ sensitive information helps meet regulatory requirements and maintain public trust.
How Decentralized Trials Can Support Meaningful Diversity
The Castor team is thrilled to see an increasing emphasis on diversity of race, gender, and even geography amongst clinical trial participants. Critically, experts call for not just increased diversity on a statistical basis, but that the studied population is representative of the distribution of the disease.
It’s a Matter of Choice: Hybrid eConsent for On-Site or Remote Patient Enrollment
Thought leaders from Castor and Lightship discuss opportunities that will help researchers develop a more successful overall strategy for their patient enrollment.
Download this eBook to gain a comprehensive overview of eConsent, how it satisfies global regulatory requirements and key considerations for ethics board approval.
3 Ways eConsent Tackles the Challenges of Modern Clinical Trials
Although eConsent struggled to gain momentum and wider acceptance pre-pandemic, it’s now a major part of clinical research. In this article, learn three ways eConsent addresses the requirements for valid informed consent.
Digital Therapeutic Cybersecurity: Keeping Participant Data Safe
DTx represent an emerging field of software-driven, evidence-based products intended to “prevent, manage, or treat a medical disease or disorder.” Cybersecurity is a concern for DTx, whether they are being evaluated through clinical research or are aiming at market release.
Using Remote Image Capture eCOA for Hybrid Dermatology Trials
Learn how a remote-first approach to dermatology trials can streamline enrollment, increase patient retention, and ensure data quality.
Trialbee and Castor Partner to Democratize Access and Simplify Enrollment to Clinical Trials Globally
Trialbee, the leading enrollment performance company, and Castor, a leading provider of decentralized and hybrid clinical trial solutions, today announced a strategic partnership to accelerate patient enrollment, optimize patient engagement, and reduce site burden for clinical trials globally.
How Medical Device Trials Can Benefit from Decentralized Methods
At Castor, we hope to see DCT extend into all trials as we work alongside researchers in the pursuit of the ultimate goal of democratized clinical research.
Castor Expands Executive Leadership Team to Scale Clinical Trial Platform Technology
announced two executive appointments to accelerate the company’s growth and impact on the industry. Kimberly Tableman as Chief Clinical Development Officer (CCDO) and Anna Wozniak as Chief Financial & Development Officer (CFDO).